APA (7th ed.) Citation

Raulet‐Bussian, C., Launois, A., Perez, F., Martin‐Toutain, I., Goubeau, L., Magnian, B., . . . Flaujac, C. (2025). Reducing Factor V Leiden Interference in Clotting‐Based Protein C Activity Assays, Including in Patients With Direct Factor Xa Oral Anticoagulant. International Journal of Laboratory Hematology, 47(3), 544. https://doi.org/10.1111/ijlh.14428

Chicago Style (17th ed.) Citation

Raulet‐Bussian, Celia, Amelie Launois, Fanny Perez, Isabelle Martin‐Toutain, Laurie Goubeau, Benjamin Magnian, Hoai‐Nam Nguyen Chi, Simon Chabay, and Claire Flaujac. "Reducing Factor V Leiden Interference in Clotting‐Based Protein C Activity Assays, Including in Patients With Direct Factor Xa Oral Anticoagulant." International Journal of Laboratory Hematology 47, no. 3 (2025): 544. https://doi.org/10.1111/ijlh.14428.

MLA (9th ed.) Citation

Raulet‐Bussian, Celia, et al. "Reducing Factor V Leiden Interference in Clotting‐Based Protein C Activity Assays, Including in Patients With Direct Factor Xa Oral Anticoagulant." International Journal of Laboratory Hematology, vol. 47, no. 3, 2025, p. 544, https://doi.org/10.1111/ijlh.14428.